Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001326732-25-000044
Filing Date
2025-04-23
Accepted
2025-04-23 16:06:50
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A xencorincdefa14a-2025.htm DEFA14A 10317
2 xncrnaa1_pagex1.jpg GRAPHIC 1204494
3 xncrnaa1_pagex2.jpg GRAPHIC 148128
  Complete submission text file 0001326732-25-000044.txt   1872495
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

EIN.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36182 | Film No.: 25861474
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)